Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $0.98.

  • Prestige Consumer Healthcare's EPS (Basic) fell 2032.52% to $0.98 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.81, marking a year-over-year decrease of 1160.09%. This contributed to the annual value of $4.32 for FY2025, which is 257.17% up from last year.
  • According to the latest figures from Q4 2025, Prestige Consumer Healthcare's EPS (Basic) is $0.98, which was down 2032.52% from $0.86 recorded in Q3 2025.
  • Prestige Consumer Healthcare's 5-year EPS (Basic) high stood at $1.23 for Q4 2024, and its period low was -$4.82 during Q1 2023.
  • In the last 5 years, Prestige Consumer Healthcare's EPS (Basic) had a median value of $1.01 in 2022 and averaged $0.72.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's EPS (Basic) tumbled by 56346.15% in 2023, and later soared by 12074.69% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's EPS (Basic) (Quarter) stood at $1.0 in 2021, then rose by 5.0% to $1.05 in 2022, then rose by 1.9% to $1.07 in 2023, then increased by 14.95% to $1.23 in 2024, then dropped by 20.33% to $0.98 in 2025.
  • Its EPS (Basic) was $0.98 in Q4 2025, compared to $0.86 in Q3 2025 and $0.96 in Q2 2025.